Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19
PLOS One · 29.04.2026 · 21 (4) · e0348065
DOI: 10.1371/journal.pone.0348065 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 29.04.2026. Verfasst von Ruinan Hu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Department of Medicine, Division of Cardiology, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: COVID-19, Nuclear Proteins, Mitochondrial Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with the infection resulting in lung inflammation, pulmonary vascular leakage and diffuse alveolar damage. Polymerase delta-interacting protein-2 (Poldip2) mediates lung inflammation and vascular permeability after lipopolysaccharide-induced acute respiratory distress syndrome; however, whether it also affects the pathological consequences of SARS-CoV-2 infection is completely unknown. Here, we assessed the role of Poldip2 in inflammation, immune cell infiltration and lung tissue damage in response to SARS-CoV-2. Our data show that Poldip2 expression was elevated in human lung vascular endothelium after infection. In a Poldip2-deficient heterozygous mouse model, acute clinical symptoms were not affected. However, seven days after infection, Poldip2 knockdown reduced viral load, decreased infiltration of myeloperoxidase (MPO)-positive neutrophils into inflamed lungs, and reduced tissue damage. Poldip2 also modulated the inflammatory response to viral infection in a heterogeneous manner, reflecting its diverse regulatory roles. These data support the concept that targeting Poldip2 could potentially attenuate severe lung injury following SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Emory University School of Medicine, Department of Medicine, Division of Cardiology, Atlanta, Georgia, United States of America.
- Emory University School of Medicine, Department of Pathology and Laboratory Medicine, Atlanta, Georgia, United States of America.
- Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
- Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America.
- University of Washington, School of Medicine, Department of Laboratory Medicine and Pathology, Seattle, Washington, United States of America.
ORCID-Profile: Willy Ju, Bernard Lassègue
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- National Heart and Lung Institute
Zitieren
APA
Hu, R., Valdivia, A., White, T., Ju, W., Brockman, M. L., Zhang, Z., Qu, H., Gafford, G., Joseph, G., Burton, S., Bassit, L., Charles, T. P., Schinazi, R. F., Levit, R. D., Derdeyn, C. A., Griendling, K. K., Lassègue, B., & Hernandes, M. S. (2026). Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19. PLOS One, 21(4), e0348065. https://doi.org/10.1371/journal.pone.0348065
Vancouver
Hu R, Valdivia A, White T, Ju W, Brockman ML, Zhang Z, et al. Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19. PLOS One. 2026;21(4):e0348065. doi:10.1371/journal.pone.0348065
BibTeX
@article{Hu2026,
author = {Hu, Ruinan and Valdivia, Alejandra and White, Taylor and Ju, Willy and Brockman, Maegan L and Zhang, Zhan and Qu, Hongyan and Gafford, Georgette and Joseph, Giji and Burton, Samantha and Bassit, Leda and Charles, Tysheena P and Schinazi, Raymond F and Levit, Rebecca D and Derdeyn, Cynthia A and Griendling, Kathy K and Lassègue, Bernard and Hernandes, Marina S},
title = {Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0348065},
doi = {10.1371/journal.pone.0348065}
}
EUVIMED